To develop a drug product, medical device or drug substance requires navigating the complex and interconnected tradeoffs in today’s global regulatory realm, while balancing shareholder demand for rapid time to market. With more than 20 years of experience, we have mastered this technical expertise and translated our experience into what we call the Pharmatech Ecosystem. This interconnected framework represents the essential elements of our programmatic End-to-End and Top-to-Bottom approach that is steeped in scientific understanding.
Although we describe our consultancy as encompassing four spheres of technical expertise, a successful product development lifecycle frequently requires knowledge in all four areas simultaneously. It is this interconnected framework of services which forms the basis for our logo and is the foundation for the Pharmatech Ecosystem.
Pharmatech understands that the regulated life sciences demand scientifically rigorous development systems. Pharmatech’s end to end expertise allows us to provide pragmatic solutions that are tailored to your company’s maturity and capabilities while still meeting the needs of regulatory authorities worldwide. Our system solutions are designed to grow as your organization grows and your business processes evolve.
The greatest challenges facing start-ups and established organizations within the regulated life sciences is the effective and efficient transformation from an organization focused upon innovation and discovery to a development organization instilled with a culture of compliance and capable of commercial product support. Organizations seeking funding or looking to potentially invest in innovative new products and drug therapies require a clear and proven roadmap to reduce program risk and shrink Time To Market.